Seattle Genetics Joins IQ
IQ is pleased to announce that Seattle Genetics (www.seattlegenetics.com/) has become its newest member, and extends a warm welcome to the company as a whole, and Seattle Genetics' delegates to the Consortium's committees and groups.
With the addition of Seattle Genetics to its membership, the IQ Consortium now has a total of 38 member companies. These companies represent a large segment of the pharmaceutical and biotechnology industries. In total, nearly 1,000 individuals from these companies are active on IQ's Board of Directors, Leadership Groups, Committees, and Working Groups.
Membership in IQ is open to any corporation and/or any subsidiary thereof which is significantly engaged in the development of new chemical entities or new molecular entities for the prevention, diagnosis or treatment of disease. For information about joining the Consortium, please see Join IQ.